Allen Frances adds to his catalog of DSM-5 mistakes with the return of the controversial – and ultimately rejected – “Psychosis Risk Disorder”, under a new name; “Attenuated Psychosis Syndrome.” Under the new name, insurance companies can be billed for an ‘Other Specified Schizophrenia Spectrum Disorder/Other Psychotic Disorder.’ “It makes absolutely no sense to pin the misleading and stigmatizing label ‘Other Specified Schizophrenia Spectrum Disorder’ on someone who, in typical settings, will have only about a 10% chance of ever becoming psychotic,” says Frances, “And certainly it makes no sense to follow this misdiagnosis with an unproven and potentially very harmful antipsychotic treatment. Preventing psychosis would be a great idea if we could really do it; but there is no reason to think we can. And reaching beyond our grasp is likely to harm those we hoped to help.”
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.